A Real Life Experience with the Comsos Regimen in Genotype 1 Chronic Hepatitis C Treatment: Including Patients with East Asian Ancestry and Decompensated Cirrhosis

BACKGROUND/AIMS: The COMSOS phase 2 trial showed high cure rates and a favorable side effect profile of a 12-week regimen of Sofosbuvir (SOF) and Simeprevir (SIM) in patients with a genotype 1 Hepatitis C infection. However, given the small number of patients in the COSMOS trial, there is uncertaint...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hawaii J Med Public Health
Autors principals: Roytman, Marina, Ramkissoon, Resham, Hong, Leena, Trujillo, Ruby, Huddleston, Leslie, Poerzgen, Peter, Seto, Todd, Tsai, Naoky
Format: Artigo
Idioma:Inglês
Publicat: University Clinical, Education & Research Associate (UCERA) 2015
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582373/
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars